men1611
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 19, 2018 (NCT03767335)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05810870 | Phase 2 | May 24, 2023 | MedSIR, Menarini Group, Quiron Group, Barcelona (Spain), University of Valencia |
| NCT04495621 | Phase 1/Phase 2 (Phase 2) | Jul 20, 2020 | Menarini Group, Universidad Autonoma de Barcelona |
| NCT03767335 | Phase 1 | Jul 19, 2018 | Institut Jules Bordet, Menarini Group |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Menarini Group | For profit | 3 | 2 | 2 | 2018 |
| Institut Jules Bordet | Academic/Hospital | 1 | 0 | 1 | 2018 |
| MedSIR | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Quiron Group, Barcelona (Spain) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Universidad Autonoma de Barcelona | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2023 |
6 organizations
Page 1 / 1